Figure 4
Figure 4. Effector cells derived from naive precursors manifest less acquisition of effector function. Cryopreserved leukapheresis samples were thawed and rested overnight. CD8+ T-cell subsets were isolated then stimulated with allogeneic feeders, anti-CD3, and IL-2. Cells were transduced to express the 1G4-α-95:LY mutant TCR 48 hours after stimulation. The following data were obtained 10-16 days after stimulation. (A-B) Expression of CD45RO, CD62L, and CCR7. Gate frequencies are indicated. Data are representative of 6 patients. (C) EOMES expression by real-time RT-PCR. Expression is relative to ACTB then normalized to the average relative expression for each patient. Data from 5 patients are shown. (D-E) IFN-γ production from 16-hour coculture with NY-ESO-1+ HLA-A2+ tumor targets as determined by intracellular staining and supernatant concentrations, respectively. Coculture with 2361R (NY-ESO-1− HLA-A2+) results in < 0.2 ng/mL of IFN-γ production in all groups. (F) Specific cell killing as determined by 51Cr release assay against the 624.38 tumor line.

Effector cells derived from naive precursors manifest less acquisition of effector function. Cryopreserved leukapheresis samples were thawed and rested overnight. CD8+ T-cell subsets were isolated then stimulated with allogeneic feeders, anti-CD3, and IL-2. Cells were transduced to express the 1G4-α-95:LY mutant TCR 48 hours after stimulation. The following data were obtained 10-16 days after stimulation. (A-B) Expression of CD45RO, CD62L, and CCR7. Gate frequencies are indicated. Data are representative of 6 patients. (C) EOMES expression by real-time RT-PCR. Expression is relative to ACTB then normalized to the average relative expression for each patient. Data from 5 patients are shown. (D-E) IFN-γ production from 16-hour coculture with NY-ESO-1+ HLA-A2+ tumor targets as determined by intracellular staining and supernatant concentrations, respectively. Coculture with 2361R (NY-ESO-1 HLA-A2+) results in < 0.2 ng/mL of IFN-γ production in all groups. (F) Specific cell killing as determined by 51Cr release assay against the 624.38 tumor line.

Close Modal

or Create an Account

Close Modal
Close Modal